A closed-loop drug delivery system is constructed in which external negative feedback is used to regulate the dynamics of a time-delayed negative feedback mechanism which regulates hormone concentration. This results in a control system composed of two time-delayed negative feedback loops arranged in parallel. Stability regions in parameter space and the location of steady states are determined for the cases when the time delays are equal and when they are unequal. The advantage of this paradigm for drug delivery is that both the steady states and stability of the multiple loop feedback system can be influenced in a precisely controllable manner.
Introduction
Endocrine disease is reflected by both quantitative and qualitative abnormalities in hormone production. An important treatment modality is hormone replacement: insulin is given to patients with diabetes, thyroid hormone to those with hypothyroidism, and so on. Ideally the strategy for hormone replacement should restore as closely as possible the normal dynamics of hormonal regulation. Open loop drug delivery systems are most commonly employed, for example, pills or injections of hormone are given at fixed intervals. However, open-loop drug delivery systems are inherently unstable since the replacement of hormone is unaffected by either current hormonal blood levels or demands, so that many problems can arise.
An alternate approach is to utilize a closed-loop drug delivery system in which blood levels are monitored by a detector whose output, in turn, affects the replacement of hormone.
The advantages of closed-loop drug delivery systems are their stability and controllability.
However, when a closed-loop drug delivery system was used to administer insulin to diabetic patients [12] , moderate amplitude oscillations in insulin-glucose were observed. Further development of such methods requires a better understanding of the stability and regulation of delayed feedback mechanisms.
The design of a closed-loop drug delivery system is reminiscent of methods designed to dynamically clamp biological control systems [4, 11, 17, 19] . In the case that the in vivo feedback loop to be regulated can be opened (Figure 1a) , the dynamics are governed by the properties of the external feedback. However, in endocrinology the feedback loop can rarely be opened and thus it becomes necessary to consider the properties of both the inserted and in vivo feedback loops (Figure 1b) .
The control of a linear delayed feedback loop by a second linear delayed feedback loop has been considered previously (see, for example, [18] ). Recently the control of a nonlinear dynamical system by an external delayed feedback loop has been considered [15, 16] ; however, the possibility that the dynamical system may also contain a delay was not considered. Here we examine the case when both the in vivo and external feedback loops are delayed negative loops.
Closed-loop drug delivery systems
We assume that the in vivo regulation of hormone concentration, x, can be described by a first-order delay differential equation of the forṁ
where α is a positive constant, τ i is the time delay, and f is a non-negative, decreasing function of x which describes the negative feedback, for example [6] f = c i θ
where n i , c i , θ i are positive constants. The time delay, τ i , arises because of, for example, finite signal transmission and hormone production times.
The drug delivery system introduces a second control loop with a feedback function, g, of the same form as f , but with parameters n e , c e , θ e which operates in parallel with the in vivo control loop as shown in Figure 1b . Thus the regulation of x in the controlled system is described byẋ
where τ e is the time delay of the external clamping feedback and h(u, v) = f (u) + g(v). The time delay, τ e , represents the time required to detect the signal and to add the hormone supplement to the circulation. In principle, this time delay can be arbitrarily adjusted so that an even longer delay can be introduced if desired. In the discussion which follows we assume that the properties of the in vivo feedback control loop as set by the constant α and the function f are fixed and examine the dynamics of (2.2) as the properties of the external feedback, g are varied.
The unique steady state value of x, x * h , is obtained from (2.2) by settingẋ = 0 and is a solution of the equation,
Since h is a non-negative decreasing function of x, x * h > 0. Equation (2.3) cannot be solved analytically for arbitrary n i and n e ; the values of x * h determined numerically as a function of θ e and n e are shown in Figure 2a . It should be noted that by suitably adjusting the properties of g, i.e. by tuning θ e , n e and c e , the value of x
The characteristic equation is found by substituting u = e −λt into (2.4) to obtain
The mechanism for the loss of stability is that a root of the characteristic equation acquires a positive real part. When a pair of complex values passes through the imaginary axis, the equation undergoes a supercritical Hopf bifurcation [9] . The Hopf bifurcation curves can be found by substituting λ = iω into (2.5) and are defined by
It can be shown that the only stable solutions of a first-order delay-differential equation with negative feedback, i.e. (2.1), are a steady state and a (slowly oscillating) limit cycle (by applying the methods presented in [7] ). Thus this local stability analysis completely describes the stable global solutions of (2.2) when τ i = τ e 1 .
The value of d =ḣ(x * h ) can be controlled by adjusting the properties of the external feedback, g. Figure 2b shows the value of d =ḣ(x * h ) in (2.6a) as a function of θ e for different values of n e . Since the function g can be rather freely adjusted, it follows from Figure 2 that both the value of the critical point, x * h , as well as its stability can be completely controlled.
Unequal time delays: τ i = τ c
In the case where the two delays τ i and τ e are not equal, the determination of the stability regions in a parameter space is more complicated algebraically. The substitution u = e −λt into the linearization of (2.2) leads to the characteristic equation
(2.7)
After letting λ = iω and separating real and imaginary parts of the ensuing equations, we are lead to the system
which immediately yields the equalities
Equations (2.9) are analogous to equations (2.6) and can be used to calculate the stability curves. Figure 3 shows the stability curves obtained for two values of τ i for fixed d f . As τ i increases, the region of parameter space for which stable steady state solutions of (2.2) exist shrinks until it becomes a narrow strip along the d g -axis. Thus, in general, stable steady state solutions of (2.2) exist always when τ e is sufficiently small. When τ i is also small additional parameter ranges exist where stable steady state solutions exist; however, it is clear on inspecting Figure 3 that such regions would be very difficult to locate empirically using a trial and error approach.
In contrast to the case when τ i = τ e , it is not possible to deduce the global behavior of (2.2) from the local stability analysis when τ i = τ e . This is because there is an additional mechanism for the loss of stability, i.e. more than one pair of complex eigenvalues can pass through the imaginary axis simultaneously. Provided that τ e and τ i are chosen such that there is only one branch of the curve of loss of stability, then it can be shown that the stability problem is equivalent to that of a delay-differential equation with one delay [13] . In such cases the global behavior can be deduced.
However, as can be seen in Figure 3 , there clearly are ranges of τ i and τ e where more than one branch of the curve of loss of stability exist as, for example, τ e is increased with fixed d g . In such cases it can be shown that the stable oscillatory solutions include 2-tori as well as limit cycles [1, 2] .
Discussion
The implementation of a closed-loop drug delivery system increases the number of feedback loops involved in endocrine regulation by one. It is known that the complexity of the dynamics produced by systems composed of multiple feedback loops becomes more complex as the number of loops increases [3, 8, 10, 14] and may, for example, include chaotic dynamics. The advantage of insertion of a synthetic feedback loop is that it is possible to influence both the steady states and stability of the multiple feedback loop system in a precisely controllable manner. Morever, by careful design of the external feedback it may be possible to learn something about the nature of the in vivo control mechanisms by studying the response of the dynamics to variations in the properties of the external feedback.
We have examined the special case of the control of a single negative feedback loop by an external negative feedback loop. This paradigm results in a control system composed of two negative feedback loops arranged in parallel. When the time delays are equal in the feedback loops, it is relatively straightforward to determine how the properties of the external feedback must be modified to control the stability and steady states of the endocrine system. The stability curves become more complex when the delays are not equal. The loss of stability results in the appearance of stable oscillations, stable limit cycles when τ i = τ e and stable limit cycles and 2-tori when τ i = τ e . Provided that the amplitude of these oscillations do not exceed certain bounds, the instability of the steady state may have few clinically significant consequences for the patient.
An unsettled question is whether the control strategy of in vivo feedback control mechanisms is designed to achieve a stable steady state or a stable limit cycle or for that matter a chaotic oscillation. Whereas linear servo-mechanism theory is well suited to the design of control mechanisms to achieve a desired steady state, nonlinear techniques must be used if the control of stable oscillatory dynamics is required. The implementation of the external types of feedback considered in this study presents few technical problems. In addition, it is feasible to introduce external positive feedback to produce "mixed" feedback of the type known to induce chaotic dynamics [4] . Thus it should be possible to directly explore the effects of various types of oscillatory dynamics on health in animal models.
FIGURE LEGENDS FIGURE 1:
Schematic diagram of a closed loop drug delivery system in which the internal feedback loop has been a) opened, and b) closed.
FIGURE 2:
Variations of the (a) steady state, x * h , and (b) slope of the feedback function at steady state,ḣ(x * h ), as (θ e , n e ) of the external feedback are varied. Calculations were performed for n e = 3, 3.5, 4, 4.5, 5, 6, 7 with θ i = 5 and n i = 3.
FIGURE 3:
Stability curves in the (d g , τ e ) plane calculated from (2.9) for (a) τ e = 1.25 and (b) τ e = 1.65 when τ i = 1. The cross-hatched areas correspond to regions of stability.
